Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy.
Saved in:
| Title: | Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. |
|---|---|
| Authors: | Findlay EG; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK., Currie AJ; School of Veterinary and Life Sciences, Murdoch University, Perth, Western Australia, Australia., Zhang A; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK., Ovciarikova J; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK., Young L; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK., Stevens H; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK., McHugh BJ; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK., Canel M; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK., Gray M; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK., Milling SWF; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Campbell JDM; Scottish National Blood Transfusion Service, Heriot Watt Research Park, Edinburgh, UK., Savill J; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK., Serrels A; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK., Davidson DJ; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.; School of Veterinary and Life Sciences, Murdoch University, Perth, Western Australia, Australia. |
| Source: | Oncoimmunology [Oncoimmunology] 2019 May 01; Vol. 8 (8), pp. 1608106. Date of Electronic Publication: 2019 May 01 (Print Publication: 2019). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2162-4011 |
|---|---|
| DOI: | 10.1080/2162402X.2019.1608106 |
